Alzheimer’s Drug Lecanemab Can Slow Disease Progression by Over Eight Years, Says New Research Thursday, December 4, 2025 alzheimer’s lecanemab nhs dementia research amyloid treatment cost diagnosis alzheimer New research presented at the Clinical Trials in Alzheimer’s Disease (CTAD) conference in San Diego suggests that the Alzheimer’s drug lecanemab, licensed in the UK but not available on the NHS, can slow disease progression … Read More
Breakthrough in Alzheimer's Research: Arginine Supplement Shows Promise in Reducing Brain Plaque Sunday, November 23, 2025 alzheimer’s arginine amyloid dementia neuroinflammation supplement protein neurodegenerative research cognitive Recent research offers promising news in the fight against Alzheimer’s disease, revealing that the amino acid arginine could play a vital role in reducing harmful brain plaque associated with the condition. Alzheimer’s, … Read More